Crossmark Global Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,080
| Closed | -$482K | – | 1463 |
|
|
2021
Q3 | $482K | Sell |
18,080
-60
| -0.3% | -$1.6K | 0.01% | 940 |
|
|
2021
Q2 | $559K | Buy |
18,140
+40
| +0.2% | +$1.23K | 0.01% | 859 |
|
|
2021
Q1 | $474K | Buy |
18,100
+1,580
| +10% | +$41.4K | 0.01% | 928 |
|
|
2020
Q4 | $416K | Buy |
+16,520
| New | +$416K | 0.01% | 925 |
|
|
2019
Q4 | – | Sell |
-12,530
| Closed | -$344K | – | 1436 |
|
|
2019
Q3 | $344K | Sell |
12,530
-160
| -1% | -$4.39K | 0.01% | 979 |
|
|
2019
Q2 | $420K | Sell |
12,690
-930
| -7% | -$30.8K | 0.01% | 903 |
|
|
2019
Q1 | $477K | Sell |
13,620
-60
| -0.4% | -$2.1K | 0.01% | 840 |
|
|
2018
Q4 | $454K | Sell |
13,680
-3,580
| -21% | -$119K | 0.01% | 803 |
|
|
2018
Q3 | $869K | Sell |
17,260
-720
| -4% | -$36.3K | 0.02% | 665 |
|
|
2018
Q2 | $1.08M | Buy |
17,980
+760
| +4% | +$45.5K | 0.03% | 567 |
|
|
2018
Q1 | $789K | Sell |
17,220
-1,650
| -9% | -$75.6K | 0.02% | 690 |
|
|
2017
Q4 | $752K | Sell |
18,870
-2,580
| -12% | -$103K | 0.02% | 756 |
|
|
2017
Q3 | $858K | Buy |
+21,450
| New | +$858K | 0.02% | 674 |
|
|
2016
Q3 | $858K | Buy |
+21,450
| New | +$858K | 0.02% | 674 |
|